ID PGM2_YEAST Reviewed; 569 AA. AC P37012; D6VZS7; DT 01-JUN-1994, integrated into UniProtKB/Swiss-Prot. DT 01-JUN-1994, sequence version 1. DT 27-MAR-2024, entry version 197. DE RecName: Full=Phosphoglucomutase 2 {ECO:0000303|PubMed:5784209}; DE Short=PGM 2 {ECO:0000303|PubMed:5784209}; DE EC=5.4.2.2 {ECO:0000269|PubMed:1100398, ECO:0000269|PubMed:23103740, ECO:0000269|PubMed:4992300}; DE AltName: Full=D-glucose-1,6-diphosphate:D-glucose-1-phosphate phosphotransferase {ECO:0000303|PubMed:14264884}; DE AltName: Full=Glucose phosphomutase 2; GN Name=PGM2 {ECO:0000303|PubMed:5784209}; GN Synonyms=GA-5 {ECO:0000303|PubMed:13887540}, GAL5 GN {ECO:0000303|PubMed:2138705}; GN OrderedLocusNames=YMR105C {ECO:0000312|SGD:S000004711}; GN ORFNames=YM9718.04C; OS Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast). OC Eukaryota; Fungi; Dikarya; Ascomycota; Saccharomycotina; Saccharomycetes; OC Saccharomycetales; Saccharomycetaceae; Saccharomyces. OX NCBI_TaxID=559292; RN [1] RP NUCLEOTIDE SEQUENCE [GENOMIC DNA]. RX PubMed=8119301; DOI=10.1111/j.1432-1033.1994.tb18601.x; RA Boles E., Liebetrau W., Hofmann M., Zimmermann F.K.; RT "A family of hexosephosphate mutases in Saccharomyces cerevisiae."; RL Eur. J. Biochem. 220:83-96(1994). RN [2] RP NUCLEOTIDE SEQUENCE [GENOMIC DNA]. RA Fu L., Bounelis P., Dey N., Browne B.L., Marchase R.B., Bedwell D.M.; RL Submitted (MAY-1994) to the EMBL/GenBank/DDBJ databases. RN [3] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RC STRAIN=ATCC 204508 / S288c; RX PubMed=9169872; RA Bowman S., Churcher C.M., Badcock K., Brown D., Chillingworth T., RA Connor R., Dedman K., Devlin K., Gentles S., Hamlin N., Hunt S., Jagels K., RA Lye G., Moule S., Odell C., Pearson D., Rajandream M.A., Rice P., RA Skelton J., Walsh S.V., Whitehead S., Barrell B.G.; RT "The nucleotide sequence of Saccharomyces cerevisiae chromosome XIII."; RL Nature 387:90-93(1997). RN [4] RP GENOME REANNOTATION. RC STRAIN=ATCC 204508 / S288c; RX PubMed=24374639; DOI=10.1534/g3.113.008995; RA Engel S.R., Dietrich F.S., Fisk D.G., Binkley G., Balakrishnan R., RA Costanzo M.C., Dwight S.S., Hitz B.C., Karra K., Nash R.S., Weng S., RA Wong E.D., Lloyd P., Skrzypek M.S., Miyasato S.R., Simison M., Cherry J.M.; RT "The reference genome sequence of Saccharomyces cerevisiae: Then and now."; RL G3 (Bethesda) 4:389-398(2014). RN [5] RP NUCLEOTIDE SEQUENCE [GENOMIC DNA]. RC STRAIN=ATCC 204508 / S288c; RX PubMed=17322287; DOI=10.1101/gr.6037607; RA Hu Y., Rolfs A., Bhullar B., Murthy T.V.S., Zhu C., Berger M.F., RA Camargo A.A., Kelley F., McCarron S., Jepson D., Richardson A., Raphael J., RA Moreira D., Taycher E., Zuo D., Mohr S., Kane M.F., Williamson J., RA Simpson A.J.G., Bulyk M.L., Harlow E., Marsischky G., Kolodner R.D., RA LaBaer J.; RT "Approaching a complete repository of sequence-verified protein-encoding RT clones for Saccharomyces cerevisiae."; RL Genome Res. 17:536-543(2007). RN [6] RP PROTEIN SEQUENCE OF 15-32 AND 265-275, SUBCELLULAR LOCATION, AND RP GLYCOSYLATION. RX PubMed=8385141; DOI=10.1016/s0021-9258(18)53101-x; RA Marchase R.B., Bounelis P., Brumley L.M., Dey N., Browne B., Auger D., RA Fritz T.A., Kulesza P., Bedwell D.M.; RT "Phosphoglucomutase in Saccharomyces cerevisiae is a cytoplasmic RT glycoprotein and the acceptor for a Glc-phosphotransferase."; RL J. Biol. Chem. 268:8341-8349(1993). RN [7] RP DISRUPTION PHENOTYPE. RX PubMed=13887540; DOI=10.1016/0006-3002(61)90924-6; RA Douglas H.C.; RT "A mutation in Saccharomyces that affects phosphoglucomutase activity and RT galactose utilization."; RL Biochim. Biophys. Acta 52:209-211(1961). RN [8] RP FUNCTION, AND DISRUPTION PHENOTYPE. RC STRAIN=8050B; RX PubMed=14264884; DOI=10.1016/0926-6569(64)90011-2; RA Tsoi A., Douglas H.C.; RT "The effect of mutation of two forms of phosphoglucomutase in RT Saccharomyces."; RL Biochim. Biophys. Acta 92:513-520(1964). RN [9] RP FUNCTION. RX PubMed=5231755; DOI=10.1073/pnas.57.5.1482; RA Joshi J.G., Hooper J., Kuwaki T., Sakurada T., Swanson J.R., Handler P.; RT "Phosphoglucomutase. V. Multiple forms of phosphoglucomutase."; RL Proc. Natl. Acad. Sci. U.S.A. 57:1482-1489(1967). RN [10] RP FUNCTION. RX PubMed=5784209; DOI=10.1128/jb.98.2.532-535.1969; RA Bevan P., Douglas H.C.; RT "Genetic control of phosphoglucomutase variants in Saccharomyces RT cerevisiae."; RL J. Bacteriol. 98:532-535(1969). RN [11] RP CATALYTIC ACTIVITY. RX PubMed=4992300; DOI=10.1093/oxfordjournals.jbchem.a129375; RA Hirose M., Sugimoto E., Sasaki R., Chiaa H.; RT "Crystallization and reaction mechanism of yeast phosphoglucomutase."; RL J. Biochem. 68:449-457(1970). RN [12] RP COFACTOR. RX PubMed=4628805; DOI=10.1016/0005-2744(72)90116-7; RA Hirose M., Sugimoto E., Chiba H.; RT "Studies on crystalline yeast phosphoglucomutase: the presence of intrinsic RT zinc."; RL Biochim. Biophys. Acta 289:137-146(1972). RN [13] RP CATALYTIC ACTIVITY, COFACTOR, BIOPHYSICOCHEMICAL PROPERTIES, AND SUBUNIT. RX PubMed=1100398; DOI=10.1111/j.1432-1033.1975.tb02282.x; RA Daugherty J.P., Kraemer W.F., Joshi J.G.; RT "Purification and properties of phosphoglucomutase from Fleischmann's RT yeast."; RL Eur. J. Biochem. 57:115-126(1975). RN [14] RP INDUCTION. RX PubMed=2138705; DOI=10.1128/mcb.10.4.1415-1422.1990; RA Oh D., Hopper J.E.; RT "Transcription of a yeast phosphoglucomutase isozyme gene is galactose RT inducible and glucose repressible."; RL Mol. Cell. Biol. 10:1415-1422(1990). RN [15] RP GLYCOSYLATION. RX PubMed=7929458; DOI=10.1016/s0021-9258(18)47136-0; RA Dey N.B., Bounelis P., Fritz T.A., Bedwell D.M., Marchase R.B.; RT "The glycosylation of phosphoglucomutase is modulated by carbon source and RT heat shock in Saccharomyces cerevisiae."; RL J. Biol. Chem. 269:27143-27148(1994). RN [16] RP LEVEL OF PROTEIN EXPRESSION [LARGE SCALE ANALYSIS]. RX PubMed=14562106; DOI=10.1038/nature02046; RA Ghaemmaghami S., Huh W.-K., Bower K., Howson R.W., Belle A., Dephoure N., RA O'Shea E.K., Weissman J.S.; RT "Global analysis of protein expression in yeast."; RL Nature 425:737-741(2003). RN [17] RP IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. RC STRAIN=ADR376; RX PubMed=17330950; DOI=10.1021/pr060559j; RA Li X., Gerber S.A., Rudner A.D., Beausoleil S.A., Haas W., Villen J., RA Elias J.E., Gygi S.P.; RT "Large-scale phosphorylation analysis of alpha-factor-arrested RT Saccharomyces cerevisiae."; RL J. Proteome Res. 6:1190-1197(2007). RN [18] RP PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-119, AND IDENTIFICATION BY RP MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. RX PubMed=18407956; DOI=10.1074/mcp.m700468-mcp200; RA Albuquerque C.P., Smolka M.B., Payne S.H., Bafna V., Eng J., Zhou H.; RT "A multidimensional chromatography technology for in-depth phosphoproteome RT analysis."; RL Mol. Cell. Proteomics 7:1389-1396(2008). RN [19] RP PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-111; THR-117 AND SER-119, AND RP IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. RX PubMed=19779198; DOI=10.1126/science.1172867; RA Holt L.J., Tuch B.B., Villen J., Johnson A.D., Gygi S.P., Morgan D.O.; RT "Global analysis of Cdk1 substrate phosphorylation sites provides insights RT into evolution."; RL Science 325:1682-1686(2009). RN [20] RP FUNCTION, CATALYTIC ACTIVITY, AND BIOPHYSICOCHEMICAL PROPERTIES. RX PubMed=23103740; DOI=10.1016/j.febslet.2012.09.042; RA Walther T., Baylac A., Alkim C., Vax A., Cordier H., Francois J.M.; RT "The PGM3 gene encodes the major phosphoribomutase in the yeast RT Saccharomyces cerevisiae."; RL FEBS Lett. 586:4114-4118(2012). RN [21] RP ACETYLATION [LARGE SCALE ANALYSIS] AT SER-2, CLEAVAGE OF INITIATOR RP METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS SPECTROMETRY RP [LARGE SCALE ANALYSIS]. RX PubMed=22814378; DOI=10.1073/pnas.1210303109; RA Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A., RA Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E., Timmerman E., RA Prieto J., Arnesen T., Sherman F., Gevaert K., Aldabe R.; RT "N-terminal acetylome analyses and functional insights of the N-terminal RT acetyltransferase NatB."; RL Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012). CC -!- FUNCTION: Major phosphoglucomutase isozyme that catalyzes the CC reversible interconversion of glucose 1-phosphate and glucose 6- CC phosphate (PubMed:5784209). Constitutes about 80-90% of the CC phosphoglucomutase activity in the cell (PubMed:14264884, CC PubMed:5231755). Key enzyme in hexose metabolism. The forward reaction CC is an essential step in the energy metabolism of galactose since the CC product of the galactose pathway enzymes in yeast is glucose 1- CC phosphate. The reverse reaction is an essential step for biosynthesis CC when carbon sources other than galactose are the energy source because CC glucose 1-phosphate is the starting point for the synthesis of UDP- CC glucose, which acts as a precursor for the synthesis of CC oligosaccharides and trehalose (PubMed:14264884). CC {ECO:0000269|PubMed:14264884, ECO:0000269|PubMed:5231755}. CC -!- CATALYTIC ACTIVITY: CC Reaction=alpha-D-glucose 1-phosphate = alpha-D-glucose 6-phosphate; CC Xref=Rhea:RHEA:23536, ChEBI:CHEBI:58225, ChEBI:CHEBI:58601; CC EC=5.4.2.2; Evidence={ECO:0000269|PubMed:1100398, CC ECO:0000269|PubMed:23103740, ECO:0000269|PubMed:4992300}; CC -!- COFACTOR: CC Name=Mg(2+); Xref=ChEBI:CHEBI:18420; CC Evidence={ECO:0000269|PubMed:1100398, ECO:0000269|PubMed:4628805}; CC Name=Zn(2+); Xref=ChEBI:CHEBI:29105; CC Evidence={ECO:0000269|PubMed:1100398, ECO:0000269|PubMed:4628805}; CC Note=Binds 1 magnesium ion per subunit. Can also use Zn(2+) as CC cofactor. {ECO:0000269|PubMed:1100398, ECO:0000269|PubMed:4628805}; CC -!- BIOPHYSICOCHEMICAL PROPERTIES: CC Kinetic parameters: CC KM=2.24 uM for alpha-D-glucose 1,6-diphosphate CC {ECO:0000269|PubMed:1100398}; CC KM=23.4 uM for alpha-D-glucose 1-phosphate CC {ECO:0000269|PubMed:1100398}; CC KM=26 uM for alpha-D-glucose 1-phosphate CC {ECO:0000269|PubMed:23103740}; CC KM=530 uM for D-ribose 1-phosphate {ECO:0000269|PubMed:23103740}; CC Vmax=33.7 umol/min/mg enzyme for alpha-D-glucose 1-phosphate CC {ECO:0000269|PubMed:23103740}; CC Vmax=0.32 umol/min/mg enzyme for D-ribose 1-phosphate CC {ECO:0000269|PubMed:23103740}; CC -!- SUBUNIT: Monomer. {ECO:0000269|PubMed:1100398}. CC -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:8385141}. CC -!- INDUCTION: Induced in response to galactose and severely repressed in CC response to glucose. {ECO:0000269|PubMed:2138705}. CC -!- PTM: O-glycosylated with mannose residues (By similarity). Substrate of CC UDP-glucose--glycoprotein glucose phosphotransferase, linking glucose CC in a phosphodiester linkage to O-linked mannose (PubMed:8385141, CC PubMed:7929458). {ECO:0000250|UniProtKB:P47244, CC ECO:0000269|PubMed:7929458, ECO:0000269|PubMed:8385141}. CC -!- DISRUPTION PHENOTYPE: Blocks galactose utilization, but does not impair CC growth on glucose. {ECO:0000269|PubMed:14264884}. CC -!- MISCELLANEOUS: Present with 3790 molecules/cell in log phase SD medium. CC {ECO:0000269|PubMed:14562106}. CC -!- SIMILARITY: Belongs to the phosphohexose mutase family. {ECO:0000305}. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; X74823; CAA52820.1; -; Genomic_DNA. DR EMBL; U09499; AAA91282.1; -; Genomic_DNA. DR EMBL; Z49702; CAA89741.1; -; Genomic_DNA. DR EMBL; AY723853; AAU09770.1; -; Genomic_DNA. DR EMBL; BK006946; DAA10001.1; -; Genomic_DNA. DR PIR; S41200; S41200. DR RefSeq; NP_013823.1; NM_001182605.1. DR AlphaFoldDB; P37012; -. DR SMR; P37012; -. DR BioGRID; 35280; 127. DR DIP; DIP-6499N; -. DR IntAct; P37012; 28. DR MINT; P37012; -. DR STRING; 4932.YMR105C; -. DR iPTMnet; P37012; -. DR MaxQB; P37012; -. DR PaxDb; 4932-YMR105C; -. DR PeptideAtlas; P37012; -. DR EnsemblFungi; YMR105C_mRNA; YMR105C; YMR105C. DR GeneID; 855131; -. DR KEGG; sce:YMR105C; -. DR AGR; SGD:S000004711; -. DR SGD; S000004711; PGM2. DR VEuPathDB; FungiDB:YMR105C; -. DR eggNOG; KOG0625; Eukaryota. DR GeneTree; ENSGT00940000173602; -. DR HOGENOM; CLU_009330_0_1_1; -. DR InParanoid; P37012; -. DR OMA; WIQDRAN; -. DR OrthoDB; 5476118at2759; -. DR BioCyc; MetaCyc:YMR105C-MONOMER; -. DR BioCyc; YEAST:YMR105C-MONOMER; -. DR Reactome; R-SCE-3322077; Glycogen synthesis. DR Reactome; R-SCE-6798695; Neutrophil degranulation. DR Reactome; R-SCE-70221; Glycogen breakdown (glycogenolysis). DR Reactome; R-SCE-70370; Galactose catabolism. DR SABIO-RK; P37012; -. DR BioGRID-ORCS; 855131; 1 hit in 10 CRISPR screens. DR PRO; PR:P37012; -. DR Proteomes; UP000002311; Chromosome XIII. DR RNAct; P37012; Protein. DR GO; GO:0005737; C:cytoplasm; IDA:SGD. DR GO; GO:0005829; C:cytosol; IBA:GO_Central. DR GO; GO:0000287; F:magnesium ion binding; IEA:InterPro. DR GO; GO:0004614; F:phosphoglucomutase activity; IMP:SGD. DR GO; GO:0005975; P:carbohydrate metabolic process; IBA:GO_Central. DR GO; GO:0019388; P:galactose catabolic process; IMP:SGD. DR GO; GO:0019255; P:glucose 1-phosphate metabolic process; IMP:SGD. DR GO; GO:0051156; P:glucose 6-phosphate metabolic process; IGI:SGD. DR GO; GO:0006006; P:glucose metabolic process; IEA:UniProtKB-KW. DR GO; GO:0005978; P:glycogen biosynthetic process; IGI:SGD. DR GO; GO:0006874; P:intracellular calcium ion homeostasis; IMP:SGD. DR GO; GO:0030003; P:intracellular monoatomic cation homeostasis; IMP:SGD. DR GO; GO:0005992; P:trehalose biosynthetic process; IGI:SGD. DR GO; GO:0006011; P:UDP-glucose metabolic process; IGI:SGD. DR CDD; cd03085; PGM1; 1. DR Gene3D; 3.40.120.10; Alpha-D-Glucose-1,6-Bisphosphate, subunit A, domain 3; 3. DR Gene3D; 3.30.310.50; Alpha-D-phosphohexomutase, C-terminal domain; 1. DR InterPro; IPR005844; A-D-PHexomutase_a/b/a-I. DR InterPro; IPR016055; A-D-PHexomutase_a/b/a-I/II/III. DR InterPro; IPR005845; A-D-PHexomutase_a/b/a-II. DR InterPro; IPR005846; A-D-PHexomutase_a/b/a-III. DR InterPro; IPR036900; A-D-PHexomutase_C_sf. DR InterPro; IPR016066; A-D-PHexomutase_CS. DR InterPro; IPR005841; Alpha-D-phosphohexomutase_SF. DR InterPro; IPR045244; PGM. DR PANTHER; PTHR22573:SF2; PHOSPHOGLUCOMUTASE; 1. DR PANTHER; PTHR22573; PHOSPHOHEXOMUTASE FAMILY MEMBER; 1. DR Pfam; PF02878; PGM_PMM_I; 1. DR Pfam; PF02879; PGM_PMM_II; 1. DR Pfam; PF02880; PGM_PMM_III; 1. DR PRINTS; PR00509; PGMPMM. DR SUPFAM; SSF55957; Phosphoglucomutase, C-terminal domain; 1. DR SUPFAM; SSF53738; Phosphoglucomutase, first 3 domains; 3. DR PROSITE; PS00710; PGM_PMM; 1. PE 1: Evidence at protein level; KW Acetylation; Carbohydrate metabolism; Cytoplasm; Direct protein sequencing; KW Glucose metabolism; Glycoprotein; Isomerase; Magnesium; Metal-binding; KW Phosphoprotein; Reference proteome. FT INIT_MET 1 FT /note="Removed" FT /evidence="ECO:0007744|PubMed:22814378" FT CHAIN 2..569 FT /note="Phosphoglucomutase 2" FT /id="PRO_0000147797" FT REGION 1..23 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT ACT_SITE 119 FT /note="Phosphoserine intermediate" FT /evidence="ECO:0000250|UniProtKB:P00949" FT BINDING 24 FT /ligand="alpha-D-glucose 1,6-bisphosphate" FT /ligand_id="ChEBI:CHEBI:58392" FT /evidence="ECO:0000250|UniProtKB:P00949" FT BINDING 119 FT /ligand="alpha-D-glucose 1,6-bisphosphate" FT /ligand_id="ChEBI:CHEBI:58392" FT /evidence="ECO:0000250|UniProtKB:P00949" FT BINDING 119 FT /ligand="Mg(2+)" FT /ligand_id="ChEBI:CHEBI:18420" FT /note="via phosphate group" FT /evidence="ECO:0000250|UniProtKB:P00949" FT BINDING 290 FT /ligand="Mg(2+)" FT /ligand_id="ChEBI:CHEBI:18420" FT /evidence="ECO:0000250|UniProtKB:P00949" FT BINDING 292 FT /ligand="Mg(2+)" FT /ligand_id="ChEBI:CHEBI:18420" FT /evidence="ECO:0000250|UniProtKB:P00949" FT BINDING 294 FT /ligand="alpha-D-glucose 1,6-bisphosphate" FT /ligand_id="ChEBI:CHEBI:58392" FT /evidence="ECO:0000250|UniProtKB:P00949" FT BINDING 294 FT /ligand="Mg(2+)" FT /ligand_id="ChEBI:CHEBI:18420" FT /evidence="ECO:0000250|UniProtKB:P00949" FT BINDING 295 FT /ligand="alpha-D-glucose 1,6-bisphosphate" FT /ligand_id="ChEBI:CHEBI:58392" FT /evidence="ECO:0000250|UniProtKB:P00949" FT BINDING 359 FT /ligand="alpha-D-glucose 1,6-bisphosphate" FT /ligand_id="ChEBI:CHEBI:58392" FT /evidence="ECO:0000250|UniProtKB:P00949" FT BINDING 378 FT /ligand="alpha-D-glucose 1,6-bisphosphate" FT /ligand_id="ChEBI:CHEBI:58392" FT /evidence="ECO:0000250|UniProtKB:P00949" FT BINDING 380 FT /ligand="alpha-D-glucose 1,6-bisphosphate" FT /ligand_id="ChEBI:CHEBI:58392" FT /evidence="ECO:0000250|UniProtKB:P00949" FT BINDING 391 FT /ligand="alpha-D-glucose 1,6-bisphosphate" FT /ligand_id="ChEBI:CHEBI:58392" FT /evidence="ECO:0000250|UniProtKB:P00949" FT MOD_RES 2 FT /note="N-acetylserine" FT /evidence="ECO:0007744|PubMed:22814378" FT MOD_RES 111 FT /note="Phosphothreonine" FT /evidence="ECO:0007744|PubMed:19779198" FT MOD_RES 117 FT /note="Phosphothreonine" FT /evidence="ECO:0007744|PubMed:19779198" FT MOD_RES 119 FT /note="Phosphoserine" FT /evidence="ECO:0007744|PubMed:18407956, FT ECO:0007744|PubMed:19779198" FT CONFLICT 27 FT /note="T -> G (in Ref. 6; AA sequence)" FT /evidence="ECO:0000305" FT CONFLICT 32 FT /note="D -> G (in Ref. 6; AA sequence)" FT /evidence="ECO:0000305" FT CONFLICT 272 FT /note="S -> A (in Ref. 6; AA sequence)" FT /evidence="ECO:0000305" SQ SEQUENCE 569 AA; 63089 MW; 45B78AFF8197645E CRC64; MSFQIETVPT KPYEDQKPGT SGLRKKTKVF KDEPNYTENF IQSIMEAIPE GSKGATLVVG GDGRYYNDVI LHKIAAIGAA NGIKKLVIGQ HGLLSTPAAS HIMRTYEEKC TGGIILTASH NPGGPENDMG IKYNLSNGGP APESVTNAIW EISKKLTSYK IIKDFPELDL GTIGKNKKYG PLLVDIIDIT KDYVNFLKEI FDFDLIKKFI DNQRSTKNWK LLFDSMNGVT GPYGKAIFVD EFGLPADEVL QNWHPSPDFG GMHPDPNLTY ASSLVKRVDR EKIEFGAASD GDGDRNMIYG YGPSFVSPGD SVAIIAEYAA EIPYFAKQGI YGLARSFPTS GAIDRVAKAH GLNCYEVPTG WKFFCALFDA KKLSICGEES FGTGSNHVRE KDGVWAIMAW LNILAIYNKH HPENEASIKT IQNEFWAKYG RTFFTRYDFE KVETEKANKI VDQLRAYVTK SGVVNSAFPA DESLKVTDCG DFSYTDLDGS VSDHQGLYVK LSNGARFVLR LSGTGSSGAT IRLYIEKYCD DKSQYQKTAE EYLKPIINSV IKFLNFKQVL GTEEPTVRT //